With the implementation of a national presumed-consent policy for organ donation, Spain became the global leader and provides a model for other countries to follow.
More than half of chronic hepatitis B e antigen–negative patients who withdraw from nucleoside or nucleotide analogue therapy experienced relapse within 4 years.